Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Divergence Linked to Possible Ecological Speciation in Blind Mole Rats: Integration of Thermal Biology and Bite Force in the Upper Galilee Blind Mole Rat (Nannospalax galili).

Integrative zoology·2026
Same author

Chromosomal Fusions Promote Speciation in Subterranean Blind Mole Rats.

Molecular ecology·2026
Same author

Genomic insights into chromosomal fusion and its evolutionary implications for zokors.

Molecular biology and evolution·2026
Same author

Protection Against <i>Salmonella</i> by Vaccination with Toxin-Antitoxin Self-Destructive Bacteria.

Vaccines·2026
Same author

Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells.

Hematology, transfusion and cell therapy·2026
Same author

Variations of Corticotropin-Releasing Factor Receptor 1α Contribute to the Blunted HPA Axis Responses to Hypoxia in Plateau Mammals.

Neuroscience bulletin·2025

Related Experiment Video

Updated: Jul 6, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NF&#954;B Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Marasmius oreades substances block NF-kappaB activity through interference with IKK activation pathway.

Roumyana D Petrova1, Jamal Mahajna, Solomon P Wasser

  • 1International Center for Cryptogamic Plants and Fungi, Institute of Evolution, University of Haifa, Mt. Carmel, Haifa 31905, Israel.

Molecular Biology Reports
|April 4, 2008
PubMed
Summary

Marasmius oreades extract fractions inhibit nuclear transcription factor kappa B (NF-kappaB) activation. These compounds block key cancer pathways, reduce cell proliferation, and induce apoptosis in breast cancer cells.

Related Experiment Videos

Last Updated: Jul 6, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NF&#954;B Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Area of Science:

  • Mycology
  • Molecular Biology
  • Cancer Research

Background:

  • Nuclear transcription factor kappa B (NF-kappaB) signaling is crucial in carcinogenesis, promoting cell proliferation, inhibiting apoptosis, and enhancing metastasis.
  • Marasmius oreades culture liquid extract demonstrated prior inhibitory effects on NF-kappaB activation via IkappaBalpha phosphorylation.

Purpose of the Study:

  • To investigate the specific mechanism of action of active compounds in Marasmius oreades extract on NF-kappaB activation.
  • To identify fractions that block the NF-kappaB pathway and assess their anti-cancer effects.

Main Methods:

  • Liquid chromatography was used to fractionate Marasmius oreades culture liquid extract.
  • Four fractions were tested for their effects on NF-kappaB activation, IkappaBalpha phosphorylation, p65 nuclear translocation, and IKK pathway activation in MCF7 breast cancer cells.
  • Cytotoxicity and anti-proliferative potential were evaluated.

Main Results:

  • All four fractions exhibited anti-proliferative effects on MCF7 cells without cytotoxicity.
  • Two fractions significantly inhibited IkappaBalpha phosphorylation and NF-kappaB reporter activity.
  • These active fractions also prevented p65 nuclear translocation, interfered with IKK activation, and induced apoptosis in MCF7 cells.

Conclusions:

  • Marasmius oreades contains low-molecular-weight bioactive substances with anticancer potential.
  • These compounds directly block NF-kappaB activation at the IKK level, offering a novel therapeutic strategy.
  • This study highlights the medicinal value of M. oreades in targeting tumorogenesis.